Maraviroc |
4,4-difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-cyclohexanecarboxamide |
(CAS 376348-65-1) |
 |
Description: |
Maraviroc is an antagonist of the C-C chemokine receptor type 5 (CCR5), inhibiting binding of the ligand RANTES with an IC50 value of 1.4 nM.Because human immunodeficiency virus (HIV) uses CCR5 to enter monocytes and macrophages, maraviroc inhibits HIV-1 replication in CCR5-expressing cells (IC50 = 2.8 nM). The pharmacokinetics of maraviroc in healthy male subjects have been delineated.
|
Product No. |
KT10102 |
Product Name |
Maraviroc |
Synonyms |
UK 427857;Celsentri;Selzentry |
Formal Name |
4,4-difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-cyclohexanecarboxamide |
CAS Number |
376348-65-1 |
Molecular Formula |
C29H41F2N5O |
Formula Weight |
513.7 |
Formulation |
A crystalline solid |
Purity |
98%min |
Stability |
2 years |
Storage |
-20°C |
Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
Price & Availability |
In Stock. Price Negotiated. |
|
Related Products: |
Abacavir
Amprenavir
Atazanavir
Darunavir
Dolutegravir
Efavirenz
Elvitegravir
Emtricitabine
Etravirine
Indinavir
Lamivudine
Nelfinavir
Rilpivirine
Raltegravir(MK-0518)
Tenofovir Disoproxil Fumarate
Tenofovir
Zidovudine
|
|